REGENERON PHARMACEUTICALS SHARES GAIN 2.3% PREMARKET AFTER BOFA GLOBAL RESEARCH UPGRADES TO 'BUY' FROM 'UNDERPERFORM'

Reuters · 5d ago

Please log in to view news